CC BY 4.0 · Int Arch Otorhinolaryngol 2024; 28(04): e597-e602
DOI: 10.1055/s-0044-1786831
Original Research

Study of Otorhinolaryngological Manifestations in Symptomatic COVID-19-Positive Patients at Tertiary Health Care Hospital: A Cross-sectional Study

1   Department of ENT, N. K. P. Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Nagpur, Maharashtra, India
,
1   Department of ENT, N. K. P. Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Nagpur, Maharashtra, India
,
1   Department of ENT, N. K. P. Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Nagpur, Maharashtra, India
,
1   Department of ENT, N. K. P. Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Nagpur, Maharashtra, India
,
1   Department of ENT, N. K. P. Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Nagpur, Maharashtra, India
› Author Affiliations
Funding There was no funding for the present research.

Abstract

Introduction The coronavirus disease 2019 (COVID-19), also referred to as the 2019 novel coronavirus, is caused by a single-stranded positive-sense RNA virus. This infectious agent spreads through respiratory routes, primarily utilizing aerosols. In our study, we shed light on ear, nose, and throat (ENT) manifestations, which can be considered as prognostic clinical biomarkers to reduce forthcoming complications among such critically ill patients. This makes it feasible for researchers to investigate or fetch early diagnosis in such cases with ease without the use of large, extensive hospital-base setups.

Objective To study the otorhinolaryngological (ENT) manifestations in symptomatic COVID-19 patients.

Methods From January to December 2021, a cross-sectional observational study was conducted at the Department of ENT of a tertiary care hospital in central India. All eligible symptomatic COVID-19 patients admitted to this institution during the study period were consecutively enrolled. The Institutional Ethics Committee gave its permission for the project.

Results Out of the total of 1,375 patients, 78% of the patients diagnosed with COVID exhibited symptoms related to the ENT, while the remaining 22% did not display any ENT manifestations. Anosmia (71.2%), sore throat (55.62%), headache (44.3%), and loss of taste (66.3%) were among the most common ENT symptoms.

Conclusion The present study highlights ENT manifestations, which play a crucial role in the early diagnosis of COVID-19 patients, ensuring faster treatment and isolation for better containment of the disease. Symptomatic treatment has shown efficacy, but objective tests are needed to prevent overestimation, understand pathogenesis, and enhance treatment.

Ethical Approval and Consent to Participate

Patients' consent was obtained.


Institutional Review Board name: N.K.P. Salve Institute of Medical Sciences and Research Centre and Lata Mangeshkar Hospital, Nagpur.


Approval Number: ECR/88/Inst/MH/2013/RR-19


Consent for Publication

All authors give permission for the publication.


Availability of Data and Materials

Data was made available by the corresponding author.


Author's Contributions

1. Dr. Disha Amar Methwani: Conceptualization, formal analysis, resources, Methodology.


2. Dr. Nitin Deosthale: Validation, Formal analysis, Writing – Review.


3. Dr. Sonali Khadakkar: Writing original Draft, Data curation, Methodology.


4. Dr. Kanchan Dhote: Formal analysis.


5. Dr. Vivek Harkare: Review, resources.


Competing Interests

No competing interest was recorded.




Publication History

Received: 02 November 2023

Accepted: 31 March 2024

Article published online:
05 July 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Al-Rohaimi AH, Al Otaibi F. Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic. Genes Dis 2020; 7 (04) 491-501
  • 2 Xu XW, Wu XX, Jiang XG. et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020; 368: m606
  • 3 Guo YR, Cao QD, Hong ZS. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2020; 7 (01) 11
  • 4 Rockx B, Kuiken T, Herfst S. et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 2020; 368 (6494): 1012-1015
  • 5 Zou L, Ruan F, Huang M. et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 2020; 382 (12) 1177-1179
  • 6 Petersen E, Koopmans M, Go U. et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis 2020; 20 (09) e238-e244
  • 7 Lovato A, de Filippis C, Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19). Am J Otolaryngol 2020; 41 (03) 102474
  • 8 Krajewska J, Krajewski W, Zub K, Zatoński T. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol 2020; 277 (07) 1885-1897
  • 9 Heller L, Mota CR, Greco DB. COVID-19 faecal-oral transmission: Are we asking the right questions?. Sci Total Environ 2020; 729: 138919
  • 10 Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91 (01) 157-160
  • 11 Drosten C, Günther S, Preiser W. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348 (20) 1967-1976
  • 12 de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14 (08) 523-534
  • 13 Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E. et al; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020; 34: 101623
  • 14 Smitha SG, Pillai N, Nayak B, Raveendran J. A Study on Otorhinolaryngological Presentations in Covid 19 Patients in a Tertiary Health Care Center. Indian J Otolaryngol Head Neck Surg 2022; 74 (Suppl. 02) 2935-2940
  • 15 El-Anwar MW, Elzayat S, Fouad YA. ENT manifestation in COVID-19 patients. Auris Nasus Larynx 2020; 47 (04) 559-564
  • 16 Prabhu RM, Patil KI, Mohammed S. et al. Otorhinolaryngological manifestations in COVID-19 Patients. Sch J Oto 2020; 5 (03) x
  • 17 Chaurasia P, Kuchhal V, Ahmad S, Rawat P. ENT manifestations in Covid-19 positive patients. Int J Health Clin Res. 2020; 3 (10) 187-191
  • 18 Vaira LA, Deiana G, Fois AG. et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck 2020; 42 (06) 1252-1258
  • 19 Alrusayyis D, Aljubran H, Alshaibani A. et al. Patterns of Otorhinolaryngological Manifestations of Covid-19: A Longitudinal Questionnaire-Based Prospective Study in a Tertiary Hospital in Saudi Arabia. J Prim Care Community Health 2022; 13: 21 501319221084158. Doi: 10.1177/21501319221084158
  • 20 Savtale S, Hippargekar P, Bhise S, Kothule S. Prevalence of Otorhinolaryngological Symptoms in Covid 19 Patients. Indian J Otolaryngol Head Neck Surg 2022; 74 (2, Suppl 2) 3378-3384
  • 21 Mahmoud MS, Taha MS, Mansour OI. et al. Comprehensive evaluation of otorhinolaryngological symptoms in COVID-19 patients. Egypt J Otolaryngol 2022; 38: 73
  • 22 Özçelik Korkmaz M, Eğilmez OK, Özçelik MA, Güven M. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol 2021; 278 (05) 1675-1685